Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation

Andrea Bacigalupo, Maria Pia Sormani, Teresa Lamparelli, Francesca Gualandi, Domenico Occhini, Stefania Bregante, Anna Maria Raiola, Carmen Di Grazia, Alida Dominietto, Elisabetta Tedone, Giovanna Piaggio, Marina Podesta, Barbara Bruno, Rosi Oneto, Anna Lombardi, Francesco Frassoni, Davide Rolla, Gianandrea Rollandi, Claudio Viscoli, Carlo Ferro & 2 others Lucia Garbarino, Maria Teresa Van Lint

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background and Objectives. Transplant-related mortality (TRM) following allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to be related to disease stage, duratiion of disease and type of donor. Furthermore, the outcome of transplants performed in the 1990s appears to be better than that of transplants done in the previous decade. The aims of this study were to determine whether these relationships still hold and whether the outcome of transplants is continuing to improve. Design and Methods. We analyzed 1180 consecutive patients with leukemia (n=979) or other hematologic malignancies (n=201) undergoing HSCT in 4 time periods: before 1990, 1991-1995, 1996-2000, and 2001-2002. Changes during these eras include increasing patient age, more unrelated transplants, more patients with advanced disease, different graft-versus-host disease (GvHD) prophylaxis, and different management of infections. Results. The actuarial 2-year transplant-related mortality (TRM) differed significantly between the transplant eras (p

Original languageEnglish
JournalHaematologica
Volume89
Issue number10
Publication statusPublished - Oct 2004

Fingerprint

Hematopoietic Stem Cell Transplantation
Transplants
Mortality
Graft vs Host Disease
Hematologic Neoplasms
Leukemia
Tissue Donors
Infection

Keywords

  • Allogeneic HSCT
  • Transplant related mortality

ASJC Scopus subject areas

  • Hematology

Cite this

Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. / Bacigalupo, Andrea; Sormani, Maria Pia; Lamparelli, Teresa; Gualandi, Francesca; Occhini, Domenico; Bregante, Stefania; Raiola, Anna Maria; Di Grazia, Carmen; Dominietto, Alida; Tedone, Elisabetta; Piaggio, Giovanna; Podesta, Marina; Bruno, Barbara; Oneto, Rosi; Lombardi, Anna; Frassoni, Francesco; Rolla, Davide; Rollandi, Gianandrea; Viscoli, Claudio; Ferro, Carlo; Garbarino, Lucia; Van Lint, Maria Teresa.

In: Haematologica, Vol. 89, No. 10, 10.2004.

Research output: Contribution to journalArticle

Bacigalupo, A, Sormani, MP, Lamparelli, T, Gualandi, F, Occhini, D, Bregante, S, Raiola, AM, Di Grazia, C, Dominietto, A, Tedone, E, Piaggio, G, Podesta, M, Bruno, B, Oneto, R, Lombardi, A, Frassoni, F, Rolla, D, Rollandi, G, Viscoli, C, Ferro, C, Garbarino, L & Van Lint, MT 2004, 'Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation', Haematologica, vol. 89, no. 10.
Bacigalupo, Andrea ; Sormani, Maria Pia ; Lamparelli, Teresa ; Gualandi, Francesca ; Occhini, Domenico ; Bregante, Stefania ; Raiola, Anna Maria ; Di Grazia, Carmen ; Dominietto, Alida ; Tedone, Elisabetta ; Piaggio, Giovanna ; Podesta, Marina ; Bruno, Barbara ; Oneto, Rosi ; Lombardi, Anna ; Frassoni, Francesco ; Rolla, Davide ; Rollandi, Gianandrea ; Viscoli, Claudio ; Ferro, Carlo ; Garbarino, Lucia ; Van Lint, Maria Teresa. / Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. In: Haematologica. 2004 ; Vol. 89, No. 10.
@article{28ad76fbfb0b4e0c8f59eecf0d4b50ec,
title = "Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation",
abstract = "Background and Objectives. Transplant-related mortality (TRM) following allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to be related to disease stage, duratiion of disease and type of donor. Furthermore, the outcome of transplants performed in the 1990s appears to be better than that of transplants done in the previous decade. The aims of this study were to determine whether these relationships still hold and whether the outcome of transplants is continuing to improve. Design and Methods. We analyzed 1180 consecutive patients with leukemia (n=979) or other hematologic malignancies (n=201) undergoing HSCT in 4 time periods: before 1990, 1991-1995, 1996-2000, and 2001-2002. Changes during these eras include increasing patient age, more unrelated transplants, more patients with advanced disease, different graft-versus-host disease (GvHD) prophylaxis, and different management of infections. Results. The actuarial 2-year transplant-related mortality (TRM) differed significantly between the transplant eras (p",
keywords = "Allogeneic HSCT, Transplant related mortality",
author = "Andrea Bacigalupo and Sormani, {Maria Pia} and Teresa Lamparelli and Francesca Gualandi and Domenico Occhini and Stefania Bregante and Raiola, {Anna Maria} and {Di Grazia}, Carmen and Alida Dominietto and Elisabetta Tedone and Giovanna Piaggio and Marina Podesta and Barbara Bruno and Rosi Oneto and Anna Lombardi and Francesco Frassoni and Davide Rolla and Gianandrea Rollandi and Claudio Viscoli and Carlo Ferro and Lucia Garbarino and {Van Lint}, {Maria Teresa}",
year = "2004",
month = "10",
language = "English",
volume = "89",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "10",

}

TY - JOUR

T1 - Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation

AU - Bacigalupo, Andrea

AU - Sormani, Maria Pia

AU - Lamparelli, Teresa

AU - Gualandi, Francesca

AU - Occhini, Domenico

AU - Bregante, Stefania

AU - Raiola, Anna Maria

AU - Di Grazia, Carmen

AU - Dominietto, Alida

AU - Tedone, Elisabetta

AU - Piaggio, Giovanna

AU - Podesta, Marina

AU - Bruno, Barbara

AU - Oneto, Rosi

AU - Lombardi, Anna

AU - Frassoni, Francesco

AU - Rolla, Davide

AU - Rollandi, Gianandrea

AU - Viscoli, Claudio

AU - Ferro, Carlo

AU - Garbarino, Lucia

AU - Van Lint, Maria Teresa

PY - 2004/10

Y1 - 2004/10

N2 - Background and Objectives. Transplant-related mortality (TRM) following allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to be related to disease stage, duratiion of disease and type of donor. Furthermore, the outcome of transplants performed in the 1990s appears to be better than that of transplants done in the previous decade. The aims of this study were to determine whether these relationships still hold and whether the outcome of transplants is continuing to improve. Design and Methods. We analyzed 1180 consecutive patients with leukemia (n=979) or other hematologic malignancies (n=201) undergoing HSCT in 4 time periods: before 1990, 1991-1995, 1996-2000, and 2001-2002. Changes during these eras include increasing patient age, more unrelated transplants, more patients with advanced disease, different graft-versus-host disease (GvHD) prophylaxis, and different management of infections. Results. The actuarial 2-year transplant-related mortality (TRM) differed significantly between the transplant eras (p

AB - Background and Objectives. Transplant-related mortality (TRM) following allogeneic hematopoietic stem cell transplantation (HSCT) has been reported to be related to disease stage, duratiion of disease and type of donor. Furthermore, the outcome of transplants performed in the 1990s appears to be better than that of transplants done in the previous decade. The aims of this study were to determine whether these relationships still hold and whether the outcome of transplants is continuing to improve. Design and Methods. We analyzed 1180 consecutive patients with leukemia (n=979) or other hematologic malignancies (n=201) undergoing HSCT in 4 time periods: before 1990, 1991-1995, 1996-2000, and 2001-2002. Changes during these eras include increasing patient age, more unrelated transplants, more patients with advanced disease, different graft-versus-host disease (GvHD) prophylaxis, and different management of infections. Results. The actuarial 2-year transplant-related mortality (TRM) differed significantly between the transplant eras (p

KW - Allogeneic HSCT

KW - Transplant related mortality

UR - http://www.scopus.com/inward/record.url?scp=19644365782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19644365782&partnerID=8YFLogxK

M3 - Article

VL - 89

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -